RCS - Directa Plus PLC - Grant of EU Patent for Shoe Soles

Directa PlusAnnouncement

20/12/2021 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20211220:nRST1178Wa&default-theme=true

RNS Number : 1178W  Directa Plus PLC  20 December 2021

 20 December 2021

 

Directa Plus plc

("Directa Plus" or the "Company")

 

Grant of EU Patent for Shoe Soles

 

Directa Plus (AIM: DCTA), a leading producer and supplier of graphene
nanoplatelets based products for use in consumer and industrial markets,
announces that the Company has been granted an EU-wide patent covering the use
of the Company's G+® pristine graphene nanoplatelets to boost the performance
of rubber-based shoe outsoles.  The priority date for the patent is July
2018.

 

The patent, titled "Shoe sole comprising graphene", covers G+® graphene
embedded in outsoles.  The specific formulation of G+® graphene for soles
provides the ability to balance opposite performance characteristics such as
durability and grip, in both dry and wet conditions.  This ability to balance
opposing performance traits is unique to Directa Plus's G+® graphene and
becomes markedly apparent on rubber-based technical shoe soles such as those
used for running, trail running, hiking, and on motorbikes.  The patent
covers both the formula for the compound and the final product outsole made
with the compound.

 

Following the grant of the patent, Directa Plus's IP portfolio will comprise
18 patent families with 72 patents granted and 25 patents pending.

 

Commenting, Giulio Cesareo, Founder and CEO of Directa Plus, said: "This EU
patent will reinforce our position in the fast-growing market for technical
footwear, attracting the attention of the major consumer product players.  We
will continue to aggressively expand our IP portfolio, covering both
production technology and applications, to continue to build value for
shareholders."

 

For further information please visit http://www.directa-plus.com/
(http://www.directa-plus.com/) or contact:

 

 Directa Plus plc                                            +39 02 36714458
 Giulio Cesareo, CEO / Giorgio Bonfanti, CFO

 Cenkos Securities plc (Nominated Adviser and Joint Broker)  +44 131 220 6939
 Neil McDonald / Adam Rae

 Singer Capital Markets (Joint Broker)                       +44 20 7496 3069
 Rick Thompson / Phil Davies

 Tavistock (Financial PR and IR)                             +44 20 7920 3150
 Simon Hudson / Heather Armstrong

 

About Directa Plus

Directa Plus (www.directa-plus.com) is one of the largest producers and
suppliers of graphene-based products for use in consumer and industrial
markets. The Company's graphene manufacturing capability uses proprietary
patented technology based on a plasma super expansion process. Starting from
natural graphite, each step of Directa Plus' production process - expansion,
exfoliation and drying - creates graphene-based materials and hybrid graphene
materials ready for a variety of uses and available in various forms such as
powder, liquid and paste.

 

This proprietary production process uses a physical process, rather than a
chemical process, to process graphite into pristine graphene nanoplatelets,
which enables Directa Plus to offer a sustainable, non-toxic product, without
unwanted by-products. Directa Plus' products are made of hybrid graphene
materials and graphene nano-platelets. The products (marketed as G+®) have
multiple applications due to its properties. These G+® products can be
categorised into various families, with different products being suitable for
specific practical applications.

 

Directa Plus was established in 2005 and is based in Lomazzo (Como, Italy) and
has been listed on the AIM market of the London Stock Exchange since May 2016.
The Company holds the Green Economy Mark from London Stock Exchange which
recognises companies that contribute to the global green economy.

 

-ends-

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAEANANFSFFFFA